ViVACCy--a drug schedule based on G2 blockade and prolonged infusion of multiple tubulin-binding agents. A pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/2194639

Cancer 1990 Aug 1 66 3 411-7

Download in:

View as

General Info

PMID
2194639